Astera Labs, Inc. (NASDAQ:ALAB) Receives $190.63 Consensus PT from Brokerages

Astera Labs, Inc. (NASDAQ:ALAB) has earned a consensus rating of “Moderate Buy” from the twenty-two analysts that are covering the company, Marketbeat.com reports. Seven investment analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company. The average twelve-month target price among brokerages that have covered the stock in the last year is $190.6316.

Several equities analysts have weighed in on ALAB shares. JPMorgan Chase & Co. raised their price target on Astera Labs from $180.00 to $215.00 and gave the company an “overweight” rating in a report on Wednesday, November 5th. Zacks Research downgraded Astera Labs from a “strong-buy” rating to a “hold” rating in a research report on Monday, October 6th. Needham & Company LLC boosted their price target on shares of Astera Labs from $205.00 to $220.00 and gave the stock a “buy” rating in a research report on Wednesday, November 5th. Northland Securities lifted their price objective on shares of Astera Labs from $175.00 to $195.00 and gave the stock an “outperform” rating in a research note on Tuesday, December 9th. Finally, Roth Mkm upped their target price on shares of Astera Labs from $200.00 to $225.00 and gave the company a “buy” rating in a research report on Wednesday, November 5th.

Astera Labs Stock Performance

Shares of NASDAQ:ALAB opened at $170.93 on Friday. The firm has a market cap of $28.87 billion, a price-to-earnings ratio of 153.99, a P/E/G ratio of 2.23 and a beta of 1.50. The firm has a fifty day moving average price of $162.86 and a 200 day moving average price of $170.82. Astera Labs has a fifty-two week low of $47.13 and a fifty-two week high of $262.90.

Astera Labs (NASDAQ:ALAB) last announced its quarterly earnings results on Tuesday, November 4th. The company reported $0.49 EPS for the quarter, topping the consensus estimate of $0.39 by $0.10. The business had revenue of $230.58 million for the quarter, compared to analysts’ expectations of $206.42 million. Astera Labs had a net margin of 27.50% and a return on equity of 13.48%. The business’s quarterly revenue was up 103.9% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.23 EPS. Astera Labs has set its Q4 2025 guidance at 0.50-0.510 EPS. As a group, research analysts predict that Astera Labs will post 0.34 earnings per share for the current year.

Insider Buying and Selling at Astera Labs

In other news, Director Manuel Alba sold 150,000 shares of the firm’s stock in a transaction that occurred on Monday, December 1st. The stock was sold at an average price of $166.18, for a total value of $24,927,000.00. Following the completion of the sale, the director directly owned 1,574,498 shares of the company’s stock, valued at $261,650,077.64. This trade represents a 8.70% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CEO Jitendra Mohan sold 90,459 shares of the business’s stock in a transaction that occurred on Monday, November 17th. The shares were sold at an average price of $144.69, for a total value of $13,088,512.71. Following the transaction, the chief executive officer directly owned 2,080,418 shares in the company, valued at approximately $301,015,680.42. This represents a 4.17% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last 90 days, insiders sold 576,936 shares of company stock valued at $87,409,540. Corporate insiders own 12.50% of the company’s stock.

Hedge Funds Weigh In On Astera Labs

A number of large investors have recently made changes to their positions in the company. Zurcher Kantonalbank Zurich Cantonalbank grew its holdings in Astera Labs by 27.6% during the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 32,975 shares of the company’s stock valued at $5,486,000 after purchasing an additional 7,142 shares during the last quarter. Belpointe Asset Management LLC grew its stake in shares of Astera Labs by 71.0% during the fourth quarter. Belpointe Asset Management LLC now owns 18,156 shares of the company’s stock valued at $3,020,000 after buying an additional 7,537 shares during the last quarter. Fortis Capital Advisors LLC grew its stake in shares of Astera Labs by 71.0% during the fourth quarter. Fortis Capital Advisors LLC now owns 18,156 shares of the company’s stock valued at $3,020,000 after buying an additional 7,537 shares during the last quarter. Wealth Enhancement Trust Services Inc. purchased a new stake in shares of Astera Labs in the fourth quarter worth approximately $2,052,000. Finally, Asset Management One Co. Ltd. lifted its stake in shares of Astera Labs by 3,470.1% during the 4th quarter. Asset Management One Co. Ltd. now owns 51,266 shares of the company’s stock worth $8,717,000 after acquiring an additional 49,830 shares during the last quarter. 60.47% of the stock is owned by hedge funds and other institutional investors.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.